These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 15517550

  • 1. The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride.
    Krishna R, Krishnaswami S, Kittner B, Sankoh AJ, Jensen BK.
    Biopharm Drug Dispos; 2004 Dec; 25(9):373-87. PubMed ID: 15517550
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO, Scheinmann P, Rosado Pinto JE, Bachert C, Hedlin G, Wahn U, Finn AF, Ruuth E.
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [Abstract] [Full Text] [Related]

  • 3. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G.
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.
    Hampel FC, Kittner B, van Bavel JH.
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):549-54. PubMed ID: 18219837
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
    Prescrire Int; 1999 Feb; 8(39):11-3. PubMed ID: 10557567
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis.
    Segall N, Grubbe RE, Levy AL, Maloney MJ, Nayak AS, Kittner B, Quesada JT.
    Allergy Asthma Proc; 2008 Feb; 29(4):380-5. PubMed ID: 18702885
    [Abstract] [Full Text] [Related]

  • 9. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
    Shon JH, Yoon YR, Hong WS, Nguyen PM, Lee SS, Choi YG, Cha IJ, Shin JG.
    Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA.
    J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
    [Abstract] [Full Text] [Related]

  • 16. Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
    Kulthanan K, Gritiyarangsan P, Sitakalin C, Charuwichitratana S, Korkij W, Aunhachoke K, Janjumratsang P, Jiamton S, Kuntiranont M, Krisadapong J, Gherunpong N, Kullavanijaya P.
    J Med Assoc Thai; 2001 Feb; 84(2):153-9. PubMed ID: 11336071
    [Abstract] [Full Text] [Related]

  • 17. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A.
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [Abstract] [Full Text] [Related]

  • 18. Fexofenadine hydrochloride--a new anti-histaminic drug.
    Amichai B, Grunwald MH, Brenner L.
    Isr Med Assoc J; 2001 Mar; 3(3):207-9. PubMed ID: 11303380
    [No Abstract] [Full Text] [Related]

  • 19. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ, Pons G, Autret-Leca E, Allegaert K, Boccard E.
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.